Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-24

Clinical Trial Update: Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation [NA]

View source ↗

Summary

A completed clinical trial investigated transcutaneous electrical vagus nerve stimulation for suppressing atrial fibrillation and inflammation; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous electrical vagus nerve stimulation

Snippet

Sponsor: University of Oklahoma | Conditions: Atrial Fibrillation, Inflammation | NA | Status: COMPLETED | Results posted: 2020-04-24